{"id":"NCT01410227","sponsor":"Baxalta now part of Shire","briefTitle":"Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)","officialTitle":"A Phase 3 Clinical Study to Determine the Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor : Recombinant Factor VIII (rVWF:rFVIII) and rVWF in the Treatment of Bleeding Episodes in Subjects Diagnosed With Von Willebrand Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11-01","primaryCompletion":"2014-02-01","completion":"2014-02-01","firstPosted":"2011-08-05","resultsPosted":"2016-04-21","lastUpdate":"2021-05-19"},"enrollment":49,"design":{"allocation":"NON_RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Von Willebrand Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Recombinant von Willebrand factor (rVWF)","otherNames":["BAX 111","rVWF"]},{"type":"DRUG","name":"Placebo","otherNames":["saline","physiologic saline"]},{"type":"BIOLOGICAL","name":"Recombinant factor VIIII (rFVIII)","otherNames":["rFVIII","ADVATE"]}],"arms":[{"label":"PK 80 Arm (minimum of 22 subjects with severe VWD)","type":"EXPERIMENTAL"},{"label":"PK 50 Arm (14 subjects with type 3 VWD)","type":"EXPERIMENTAL"},{"label":"PK 50 Only Arm (minimum of 7 subjects with type 3 VWD)","type":"EXPERIMENTAL"},{"label":"Treatment Only (up to 7 subjects independent of VWD subtype)","type":"EXPERIMENTAL"}],"summary":"The purpose of this Phase 3 study is to assess the pharmacokinetics of rVWF:rFVIII and rVWF, and to assess the safety and efficacy of rVWF:rFVIII and rVWF in the treatment of bleeding events in subjects with severe hereditary von Willebrand disease (VWD).","primaryOutcome":{"measure":"Percentage of Participants With Treatment Success for Treated Bleeding Episodes","timeFrame":"For 12 months after first infusion of rVWF:rFVIII or rVWF","effectByArm":[{"arm":"Full Analysis Set","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":21},"locations":{"siteCount":52,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Germany","India","Italy","Japan","Netherlands","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["26239086"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":37},"commonTop":["Headache","Iron deficiency anaemia","Vomiting","Upper respiratory tract infection","Arthralgia"]}}